tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $18.46. This is a potential upside of $18.46 (0%) from yesterday's end of day stock price of $0.
Catabasis Pharmaceuticals's activity chart (see below) currently has 10 price targets and 18 ratings on display.
Analysts average stock forecasts to be materialized ratio is 36.11% with an average time for these price targets to be met of 150 days.
Most recent stock forecast was given by HARTAJ SINGH from OPPENHEIMER on 11-Mar-2021. First documented stock forecast 20-Jul-2015.
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
30
$22.93 (324.33%)
3 years 1 months 12 days ago
1/3 (33.33%)
$9.24 (44.51%)
63
Buy
6.9
$-0.17 (-2.40%)
90
3 years 5 months 21 days ago
1/4 (25%)
$-1.26 (-15.44%)
350
Buy
150
$142.93 (2021.64%)
6 years 5 months 3 days ago
1/2 (50%)
$47.4 (46.20%)
37
What is CATB (Catabasis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CATB (Catabasis Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CATB (Catabasis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CATB (Catabasis Pharmaceuticals)?
Which analyst is the currently most bullish on CATB (Catabasis Pharmaceuticals)?
Which analyst is the currently most reserved on CATB (Catabasis Pharmaceuticals)?
